£737.00

It has never been this cheap. We have no record of a lower price.

£737 today · cheaper than every other day in the last 3 months

CREATESPACE Estimation of Febuxostat

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days · 35 data points (no recent data)

Historical
Generating forecast…
£737.00 £700.15 £714.89 £729.63 £744.37 £759.11 £773.85 11 August 2026 19 August 2026 28 August 2026 05 September 2026 14 September 2026
View at Amazon ↗

Price data last checked 56 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price
35 days 0 9 18 26 35 £737 Days at Price

Price Analysis

Most common price: £737 (35 days, 100.0%)

Price range: £737 - £737

Price levels: 1 different prices over 35 days

Description

Method validation, according to the United States Pharmacopoeia (USP), is performed to ensure that an analytical methodology is accurate, specific,reproducible, and rugged over the specified range that an analyte will be analyzed. Regulated laboratories must perform method validation in order to be in compliance with FDA regulations. In a 1987 guideline (Guideline for Submitting Samples and Analytical Data for Methods Validation).

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Development of Analytical Methods For Estimation of Moclobemide
80% match

Development of Analytical Methods For Estimation of Moclobemide

CREATESPACE

£733.76 14 Sep 2026
Validation for the Determination of Esomeprazole and Itopride
80% match

Validation for the Determination of Esomeprazole and Itopride

CREATESPACE

£734.66 27 Oct 2026
Validation for Escitalopram Oxalate in Pharmaceutical Dosage Forms
80% match

Validation for Escitalopram Oxalate in Pharmaceutical Dosage Forms

CREATESPACE

£734.66 27 Oct 2026
Analytical Method Development of Linezolid in Bulk and Its Dosage Forms
79% match

Analytical Method Development of Linezolid in Bulk and Its Dosage Forms

CREATESPACE

£733.76 14 Sep 2026
Analytical Methods for Pioglitazone in Bulk and Its Dosage Forms
79% match

Analytical Methods for Pioglitazone in Bulk and Its Dosage Forms

CREATESPACE

£734.66 27 Oct 2026
Validation of Rimonabant
79% match

Validation of Rimonabant

CREATESPACE

£735.83 27 Oct 2026
Analytical method development of Rabeprazole and Ondansetron
79% match

Analytical method development of Rabeprazole and Ondansetron

CREATESPACE

£734.66 27 Oct 2026
Formulation And Evaluation of 5-Fluorouracil
79% match

Formulation And Evaluation of 5-Fluorouracil

CREATESPACE

£570.50 27 Oct 2026
Estimation Of Levofloxacin And Ornidazole
78% match

Estimation Of Levofloxacin And Ornidazole

CREATESPACE

£734.66 27 Oct 2026
Estimation of Repaglinide
78% match

Estimation of Repaglinide

CREATESPACE

£734.66 27 Oct 2026
Estimation of Nateglinide
77% match

Estimation of Nateglinide

CREATESPACE

£733.76 27 Oct 2026
Evaluation of Antihyperglycemic Derivatives
77% match

Evaluation of Antihyperglycemic Derivatives

CREATESPACE

£735.83 27 Oct 2026
Bioanalytical Techniques
77% match

Bioanalytical Techniques

CREATESPACE

£263.32 27 Oct 2026
Quality Studies of Formulations
77% match

Quality Studies of Formulations

CREATESPACE

£128.44 30 Oct 2026
Estimation of Lamotrigine
77% match

Estimation of Lamotrigine

CREATESPACE

£734.66 30 Oct 2026
Analysis of Food Products
77% match

Analysis of Food Products

CREATESPACE

£489.72 27 Oct 2026
Estimation of Nicotine
77% match

Estimation of Nicotine

CREATESPACE

£738.08 27 Oct 2026
Estimation of Carvedilol in Human Plasma
77% match

Estimation of Carvedilol in Human Plasma

CREATESPACE

£735.83 27 Oct 2026
Analysis of Cinitapride and Rabeprazole
76% match

Analysis of Cinitapride and Rabeprazole

CREATESPACE

£737.00 27 Oct 2026
Violations Of 21 CFR Part 820 - Quality System Regulation, Subpart M Records: Warning Letters Issued by U.S. Food and Drug Administration: Volume 15 (FDA Warning Letters Analysis)
76% match

Violations Of 21 CFR Part 820 - Quality System Regulation, Subpart M Records: Warning Letters Issued by U.S. Food and Drug Administration: Volume 15 (FDA Warning Letters Analysis)

CREATESPACE

£95.12 28 Oct 2026
Estimation of Deflazacort
76% match

Estimation of Deflazacort

CREATESPACE

£735.83 30 Oct 2026
Spectral Analysis And Pharmacological Activities Of Isolated Compound
76% match

Spectral Analysis And Pharmacological Activities Of Isolated Compound

CREATESPACE

£197.07 27 Oct 2026
Violations Of 21 CFR Part 58 - Good Laboratory Practice for Nonclinical Laboratory: Warning Letters Issued by U.S. Food and Drug Administration: Volume 3 (FDA Warning Letters Analysis)
76% match

Violations Of 21 CFR Part 58 - Good Laboratory Practice for Nonclinical Laboratory: Warning Letters Issued by U.S. Food and Drug Administration: Volume 3 (FDA Warning Letters Analysis)

CREATESPACE

£63.42 27 Oct 2026
Violations Of 21 CFR Part 820 Quality System Regulation, Subparts D-F: Document Controls, Purchasing Controls, Identification and Traceability: ... Volume 10 (FDA Warning Letters Analysis)
76% match

Violations Of 21 CFR Part 820 Quality System Regulation, Subparts D-F: Document Controls, Purchasing Controls, Identification and Traceability: ... Volume 10 (FDA Warning Letters Analysis)

CREATESPACE

£75.97 27 Oct 2026